Related Experiment Video
Updated: May 5, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
11.4K
Progressive supranuclear palsy: clinical and pathological diagnosis
E Tolosa1, F Valldeoriola, F Cruz-Sánchez
1Movement Disorder Unit, Neurology Service, Hospital Cliínici Provincial, Faculty of Medicine, University of Barcelona, Barcelona, SpainUniversity of Barcelona Neurological Tissue Bank, Neurology Service, Hospital Cliínici Provincial, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
European Journal of Neurology
|November 29, 2013
Summary
Diagnosing progressive supranuclear palsy (PSP) is challenging due to its varied clinical and pathological presentations. This review explores diagnostic difficulties and current criteria for PSP.
Area of Science:
- Neurology
- Pathology
Background:
- Progressive supranuclear palsy (PSP) is a neurodegenerative disease.
- PSP presents with heterogeneous clinical and pathological features.
- Diagnostic challenges are common in clinical practice.
Purpose of the Study:
- To discuss clinical settings where diagnosing PSP is difficult.
- To review the pathology of progressive supranuclear palsy.
- To examine current clinical and pathological diagnostic criteria for PSP.
Main Methods:
- Literature review of clinical and pathological studies on PSP.
- Analysis of diagnostic criteria for progressive supranuclear palsy.
- Discussion of challenging diagnostic scenarios in PSP.
Main Results:
- PSP's heterogeneity complicates accurate diagnosis.
- Understanding specific clinical presentations aids in diagnosis.
- Pathological findings are crucial for definitive diagnosis.
Conclusions:
- Accurate diagnosis of PSP requires careful consideration of clinical and pathological data.
- Reviewing diagnostic criteria can improve diagnostic accuracy.
- Further research may refine diagnostic approaches for PSP.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:23Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
01:21Huntington Disease l: Introduction
166
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
166
01:11Alterations in Muscle Tone lll
36
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
36